SYK:NYE-Stryker Corporation (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 361.35

Change

+1.85 (+0.51)%

Market Cap

N/A

Volume

1.43M

Analyst Target

USD 217.70
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ABT Abbott Laboratories

+0.12 (+0.11%)

USD 196.14B
MDT Medtronic PLC

+0.06 (+0.07%)

USD 115.25B
STE STERIS plc

+0.34 (+0.14%)

USD 23.37B
ZBH Zimmer Biomet Holdings Inc

+1.21 (+1.14%)

USD 21.67B
SNN Smith & Nephew SNATS Inc

+0.29 (+0.95%)

USD 13.37B
GMED Globus Medical

+0.17 (+0.24%)

USD 9.42B
BIO Bio-Rad Laboratories Inc

+16.55 (+5.24%)

USD 9.32B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 8.85B
PEN Penumbra Inc

+4.74 (+2.54%)

USD 7.80B
GKOS Glaukos Corp

+1.19 (+0.94%)

USD 7.15B

ETFs Containing SYK

CIB0:XETRA VanEck Bionic Engineering.. 10.43 % 0.00 %

+0.02 (+0.95%)

USD 6.28M
UMDV:SW iShares US Medical Device.. 10.25 % 0.00 %

N/A

N/A
CYBG:LSE VanEck Bionic Engineering.. 9.94 % 0.00 %

-0.13 (0.95%)

N/A
JGRW Trust For Professional Ma.. 5.47 % 0.00 %

+0.25 (+0.95%)

N/A
HHL-U:CA Harvest Healthcare Leader.. 5.09 % 0.00 %

+0.04 (+0.95%)

N/A
HHL-B:CA Harvest Healthcare Leader.. 5.09 % 0.00 %

+0.05 (+0.95%)

N/A
DX2Z:XETRA Xtrackers - S&P Select Fr.. 4.26 % 0.00 %

-0.05 (0.95%)

USD 0.10B
CWS AdvisorShares Focused Equ.. 4.19 % 0.68 %

+0.53 (+0.95%)

USD 0.17B
MHCD:CA Middlefield Healthcare Di.. 3.90 % 0.00 %

N/A

CAD 0.16B
GOAI:PA Amundi Stoxx Global Artif.. 3.61 % 0.00 %

+0.24 (+0.95%)

USD 0.86B
GOAI:XETRA Amundi Stoxx Global Artif.. 3.61 % 0.00 %

+0.30 (+0.95%)

USD 0.98B
DRUP GraniteShares ETF Trust -.. 2.55 % 0.00 %

+0.43 (+0.95%)

USD 0.06B
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

+0.26 (+0.95%)

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
XSFD:LSE Xtrackers S&P Select Fron.. 0.00 % 0.00 %

-0.01 (0.95%)

USD 0.09B
XSFR:LSE Xtrackers S&P Select Fron.. 0.00 % 0.00 %

-6.50 (0.95%)

USD 0.09B
GOAI:F Amundi Index Solutions - .. 0.00 % 0.00 %

+1.15 (+0.95%)

N/A
TACE 0.00 % 0.00 %

N/A

N/A
AGNG Global X Aging Population.. 0.00 % 0.00 %

+0.09 (+0.95%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.67% 71% C- 81% B-
Dividend Return 0.53% 29% F 9% A-
Total Return 21.20% 71% C- 78% C+
Trailing 12 Months  
Capital Gain 32.16% 71% C- 79% B-
Dividend Return 0.88% 43% F 11% F
Total Return 33.04% 71% C- 76% C+
Trailing 5 Years  
Capital Gain 69.16% 75% C 77% C+
Dividend Return 6.09% 38% F 19% F
Total Return 75.25% 79% B- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.24% 75% C 77% C+
Dividend Return 15.39% 81% B- 75% C
Total Return 1.15% 50% F 26% F
Risk Return Profile  
Volatility (Standard Deviation) 21.15% 84% B 49% F
Risk Adjusted Return 72.77% 97% N/A 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.